MedGenome
South Asia's largest genomics-driven diagnostics and research services company, offering 1,300+ genetic tests across oncology, inherited disease, reproductive health, infectious disease and preventive wellness through a CAP-accredited lab network in India, with additional operations in the US, Singapore and Africa.
MedGenome: Funding Rounds
| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 21 Jul 2025 | Series E | $47.5 Mn | MAJ Invest Novo Holdings Sofina | source |
| 30 Aug 2022 | Undisclosed | $50 Mn | Novo Holdings LeapFrog Investments Sofina | source |
| 15 Jul 2021 | Undisclosed | $31 Mn | International Finance Corporation (IFC) | source |
| 1 Apr 2020 | Series D | $55 Mn | LeapFrog Investments Sequoia Capital India Sofina | source |
| 5 Mar 2018 | Series C | $10 Mn | HDFC Asset Management HDFC Life HDFC Ltd. | source |
| 28 Aug 2017 | Series C | $30 Mn | Sequoia Capital India Sofina Kris Gopalakrishnan Lakshmi Narayanan Zodius Capital | source |
| 22 Jul 2015 | Series B | $20 Mn | Sequoia Capital India | source |
| 4 Jun 2014 | Series A | $4 Mn | Emerge Venture Papillon Capital Ambiga Dhiraj Dan Peterson Dmitri Mehlhorn Tim McLaughlin | source |
Acquisitions
| Date | Acquirer | Acquired | Amount | Source |
|---|---|---|---|---|
| 18 May 2026 | MedGenome | Siddhi Diagnostics & Research Centre | Undisclosed | source |
| 2 Mar 2026 | MedGenome | Medcare Management Services | Undisclosed | source |
| 4 Nov 2025 | MedGenome | Green Cross Genetics Lab | Undisclosed | source |
| 11 Jul 2024 | MedGenome | GenX Diagnostics | Undisclosed | source |
| 27 May 2023 | MedGenome | Prognosis Laboratories | Undisclosed | source |
| 23 Nov 2021 | MedGenome | Trident Diagnostics & Healthcare | Undisclosed | source |
| 24 Feb 2016 | MedGenome | Lifecode Health | Undisclosed | source |
Recent Signals
-
17 Oct 2024 · growth-traction
MedGenome marks 10 years of genomics diagnostics in India source -
11 Jul 2023 · growth-traction
MedGenome first in South Asia to deploy Illumina's NovaSeq X Plus, launches KaryoSeq test source -
29 Sep 2021 · growth-traction
MedGenome launches direct-to-consumer genomics brand Genessense source -
12 Feb 2016 · ma-strategic
MedGenome commits $10M as founding member of GenomeAsia 100K consortium source
News on MedGenome
No coverage of MedGenome linked yet.
L Litmus · by Lapaas
Got an idea like this one? Validate it with the same 9-block framework, free.
Start Free ValidationFAQs on MedGenome
Who founded MedGenome?
MedGenome was founded by Sam Santhosh, Mahesh Pratapneni in 2013.
How much funding has MedGenome raised?
MedGenome has raised $247.5 Mn across 8 tracked funding round(s), most recently on 2025-07-21. Figures are compiled from cited public sources.
Who are the investors in MedGenome?
Investors in MedGenome include MAJ Invest, Novo Holdings, Sofina, LeapFrog Investments, International Finance Corporation (IFC).
What does MedGenome do?
South Asia's largest genomics-driven diagnostics and research services company, offering 1,300+ genetic tests across oncology, inherited disease, reproductive health, infectious disease and preventive wellness through a CAP-accredited lab network in India, with additional operations in the US, Singapore and Africa.
Where is MedGenome headquartered?
MedGenome is headquartered in Bengaluru, Karnataka, India.
What is MedGenome's business model?
MedGenome's core value proposition centers on South Asia's largest CAP-accredited genomics lab, Broad test menu, Global quality at lower cost, India's most diverse genetic dataset.
How does MedGenome make money?
MedGenome's cited revenue streams include Clinical diagnostic testing fees, Bioinformatics & SaaS offerings, Research & drug-discovery data access.